Common use of Supply of Investigational Drug Clause in Contracts

Supply of Investigational Drug. The Sponsor and/or its Affiliate shall supply the Institution with quantities of the Investigational Drug adequate for the Institution to conduct the Study in accordance with the Protocol. The Investigational Drug shall remain the sole property of the Sponsor and/or its Affiliate. The Institution shall take reasonable steps to ensure that it has adequate supplies of the Investigational Drug, shall store, use, handle, and return or dispose of the Investigational Drug in accordance with the Protocol, and shall not use any Investigational Drug after its labeled expiration date.

Supply of Investigational Drug. The Sponsor and/or its Affiliate shall supply the Institution Institution/Principal Investigator with quantities of the Investigational Drug adequate for the Institution Institution/Principal Investigator to conduct the Study in accordance with the Protocol. The Investigational Drug shall remain the sole property of the Sponsor and/or its Affiliate. The Institution Institution/Principal Investigator shall take reasonable steps to ensure that it has adequate supplies of the Investigational Drug, shall store, use, handle, and return or dispose of the Investigational Drug in accordance with the Protocol, and shall not use any Investigational Drug after its labeled expiration date.

Supply of Investigational Drug. The Sponsor and/or its Affiliate shall supply the Institution Institution/Principal Investigator with quantities of the Investigational Drug adequate for the Institution Institution/Principal Investigator to conduct the Study in accordance with the Protocol. The Investigational Drug shall remain the sole property of the Sponsor and/or its Affiliate. The Institution Institution/Principal Investigator shall take reasonable steps to ensure that it has adequate supplies of the Investigational Drug, shall store, use, handle, and return or dispose of the Investigational Drug in accordance with the Protocol, and shall not use any Investigational Drug after its labeled expiration date.. 3.2

Supply of Investigational Drug. The Sponsor and/or its Affiliate shall supply the Institution Institution/Principal Investigator with quantities of the Investigational Drug adequate for the Institution Institution/Principal Investigator to conduct the Study in accordance with the Protocol. The Investigational Drug shall remain the sole property of the Sponsor and/or its Affiliate. The Institution Institution/Principal Investigator shall take reasonable steps to ensure that it has adequate supplies of the Investigational Drug, shall store, use, handle, and return or dispose of the Investigational Drug in accordance with the Protocol, and shall not use any Investigational Drug after its labeled expiration date.. 3.3